|4Apr 6, 5:05 PM ET

Jain Rita 4

4 · ANAPTYSBIO, INC · Filed Apr 6, 2023

Insider Transaction Report

Form 4
Period: 2023-04-03
Jain Rita
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-04-03+8,0158,015 total
    Exercise: $22.09Exp: 2033-04-02Common Stock (8,015 underlying)
  • Award

    Stock Option (right to buy)

    2023-04-03+10,60010,600 total
    Exercise: $22.09Exp: 2033-04-02Common Stock (10,600 underlying)
  • Award

    Restricted Stock Unit

    2023-04-03+3,9003,900 total
    Common Stock (3,900 underlying)
  • Award

    Restricted Stock Unit

    2023-04-03+3,2343,234 total
    Common Stock (3,234 underlying)
Footnotes (5)
  • [F1]The stock option vests as of 1/36 of the total shares monthly beginning on May 6, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
  • [F2]The stock option vests as of 1/9 of the total shares monthly beginning on May 6, 2023 and each month thereafter until fully vested on January 6, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
  • [F3]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F4]The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date.
  • [F5]The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION